Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Breast Neoplasms"
topic_facet:"Medical Condition: Breast Cancer"
topic_facet:"Phase: Phase 1"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Breast+Neoplasms%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Breast+Cancer%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Breast+Neoplasms%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Breast+Cancer%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Breast+Neoplasms%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Breast+Cancer%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
PubPharm (147)
1
A Phase I Dose Escalation Study of Eribulin Plus Weekly Carboplatin for Metastatic Breast Patients : A Phase I Dose Escalation Study of Eribulin in Combination With Weekly Carboplatin for the Treatment of Metastatic Breast Cancer
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
2
Study of CoQ10 During One Cycle of Doxorubicin Treatment for Breast Cancer : Phase I Randomized, Placebo-Controlled, Cross-Over, Dose-Finding Pharmacokinetic Study of CoQ10 During One Cycle of Doxorubicin Treatment for Breast Cancer
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
3
Focused Ultrasound and Pembrolizumab in Metastatic Breast Cancer : Focused Ultrasound Therapy to Augment Antigen Presentation and Immune-Specificity of Checkpoint Inhibitor Therapy With Pembrolizumab in Metastatic Breast Cancer
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
4
A Phase Ib Study of HS-10352 Plus Fulvestrant in Patients With Advanced Breast Cancer : A Phase Ib, Open-label, Multicenter Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of HS-10352 in Combination With Fulvestrant in Patients With Hormone Receptor (HR) Positive, Human Epidermal Growth Factor 2 (HER2)-Negative, PIK3CA Mutation, Locally Advanced or Metastatic Breast Cancer
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
5
AGE Levels in ER+ Metastatic Breast Cancer Patients Receiving Endocrine Therapy : Pilot Study of Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in ER+, Metastatic Breast Cancer Patients Receiving Endocrine Therapy
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
6
A Study of ZN-c5 in Participants With Breast Cancer : A Phase 1 Open-Label, Multicenter Study to Evaluate Biomarkers for ZN-c5 in Subjects With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
7
A Study To Assess The Tolerability And Clinical Activity Of Gedatolisib In Combination With Palbociclib/Letrozole Or Palbociclib/Fulvestrant In Women With Metastatic Breast Cancer : PHASE 1B STUDY TO ASSESS THE SAFETY, TOLERABILITY, AND CLINICAL ACTIVITY OF GEDATOLISIB IN COMBINATION WITH PALBOCICLIB AND EITHER LETROZOLE OR FULVESTRANT IN WOMEN WITH METASTATIC OR LOCALLY ADVANCED/RECURRENT BREAST CANCER (MBC)
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
8
A Study Of Pembrolizumab In Combination With Trastuzumab-DM1 : A Phase 1b Study Of Pembrolizumab In Combination With Trastuzumab-DM1 In Metastatic HER2-Positive Breast Cancer
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
9
Safety, Pharmacodynamics, Pharmacokinetics, and Efficacy of Tomivosertib Combined With Paclitaxel in Advanced Breast Cancer : A Trial to Assess the Safety, Pharmacodynamic Effects, Pharmacokinetics and Efficacy of the MNK Inhibitor Tomivosertib (eFT508) in Combination With Paclitaxel, Following a Run-in Period of Tomivosertib Monotherapy, in Patients With Advanced Breast Cancer
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
10
Dose Escalation Study of HBI-8000 in Combination With Paclitaxel and Trastuzumab in Women With Advanced or Metastatic HER2+ Breast Cancer : Phase I Dose Escalation Study of HBI-8000 in Combination With Paclitaxel and Trastuzumab in Women With Advanced or Metastatic HER2+ Breast Cancer
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[15]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Breast Neoplasms
Filter aufheben
Thema: Medical Condition: Breast Cancer
Filter aufheben
Thema: Phase: Phase 1
Medienart
147
Aufsätze
147
E-Artikel
147
E-Ressourcen
Zeitschriftentitel
147
ClinicalTrials.gov
Thema
147
610
Breast Neoplasms
Medical Condition: Breast Cancer
Phase: Phase 1
147
Study Type: Interventional
92
Recruitment Status: Completed
25
Recruitment Status: Terminated
12
Recruitment Status: Withdrawn
8
Recruitment Status: Unknown status
6
Triple Negative Breast Neoplasms
5
Recruitment Status: Recruiting
3
Recruitment Status: Active, not recruiting
2
Carcinoma
1
Fever
1
Necrosis
1
Obesity
1
Recruitment Status: Not yet recruiting
1
Recruitment Status: Suspended
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
46
2020-
98
2010-2019
3
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
147
Englisch
Haven't found what you're looking for?
Wird geladen...